Metraipolis › archive › dc_2f8adec92d2c

Nonclinical regulatory considerations for investigational new drug applications for regulatory T cell therapies — Europe PMC PMID:41368312

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41368312
DOI
10.3389/fmed.2025.1626067
License (as archived)
solo-consultazione
Archived
2026-11-08T07:54:02.971Z
SHA-256 of the archived text
42a0a00e82b587111042836af0aa16ad4246eda89b1698087e7346e7c9bda632
Stable URL of this page
https://metraipolis.com/documento/dc_2f8adec92d2c

How to cite

Nonclinical regulatory considerations for investigational new drug applications for regulatory T cell therapies — Europe PMC PMID:41368312 — Europe PMC (en), https://europepmc.org/article/MED/41368312 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f8adec92d2c (Metraipolis archive dc_2f8adec92d2c, sha256 42a0a00e82b587111042836af0aa16ad4246eda89b1698087e7346e7c9bda632)
BibTeX
@misc{dc2f8adec92d2c,
  title = {Nonclinical regulatory considerations for investigational new drug applications for regulatory T cell therapies — Europe PMC PMID:41368312},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41368312},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f8adec92d2c; sha256 42a0a00e82b587111042836af0aa16ad4246eda89b1698087e7346e7c9bda632},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41368312. Agents can read the archived copy with the MCP tool read_document.